Selected article for: "analysis effect and ICU requirement"
Author: Otero, Diego López; López-Pais, Javier; Antonio, Carla Eugenia Cacho; Muiños, Pablo José Antúnez; Ferreiro, Teba González; Pérez-Poza, Marta; García, Óscar Otero; Fernández, Brais Díaz; Fernández, María Bastos; Cruz, Noelia Bouzas; Pena, Xoan Carlos Sanmartín; Román, Alfonso Varela; Romero, Manuel Portela; Cuadrado, Luis Valdés; Reino, Antonio Pose; Ramón González-Juanatey, José
Title: Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry
  • Cord-id: utgnwox8
  • Document date: 2020_6_5
    • ID: utgnwox8
    Snippet: ABSTRACT Introduction and objectives: Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection. Methods: Single-center, ret
    Document: ABSTRACT Introduction and objectives: Coronavirus disease (COVID-19) has been designated a global pandemic by the World Health Organization. It is unclear whether previous treatment with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) affects the prognosis of COVID-19 patients. The aim of this study was to evaluate the clinical implications of previous treatment with ACEI/ARB on the prognosis of patients with COVID-19 infection. Methods: Single-center, retrospective, observational cohort study based on all the inhabitants of our health area. Analyses of main outcomes (mortality, heart failure, hospitalization, intensive care unit [ICU] admission, and major acute cardiovascular events [a composite of mortality and heart failure]) were adjusted by multivariate logistic regression and propensity score matching models. Results: Of the total population, 447 979 inhabitants, 965 patients (0.22%) were diagnosed with COVID-19 infection, and 210 (21.8%) were under ACEI or ARB treatment at the time of diagnosis. Treatment with ACEI/ARB (combined and individually) had no effect on mortality (OR, 0.62; 95%CI, 0.17-2.26; P = .486), heart failure (OR, 1.37; 95%CI, 0.39-4.77; P = .622), hospitalization rate (OR, 0.85; 95%CI, 0.45-1.64; P = .638), ICU admission (OR, 0.87; 95%CI, 0.30-2.50; P = .798), or major acute cardiovascular events (OR, 1.06; 95%CI, 0.39-2.83; P = .915). This neutral effect remained in a subgroup analysis of patients requiring hospitalization. Conclusions: Previous treatment with ACEI/ARB in patients with COVID-19 had no effect on mortality, heart failure, requirement for hospitalization, or ICU admission. Withdrawal of ACEI/ARB in patients testing positive for COVID-19 would not be justified, in line with current recommendations of scientific societies and government agencies.

    Search related documents:
    Co phrase search for related documents
    • acei arb therapy and logistic regression multivariate analysis: 1, 2, 3, 4
    • acei arb treatment and acute respiratory distress syndrome: 1
    • acei arb treatment and acute respiratory distress syndrome immune response: 1
    • acei arb treatment and logistic regression: 1, 2, 3, 4
    • acei arb treatment and logistic regression multivariate analysis: 1
    • acei enzyme inhibitor and acute respiratory distress syndrome: 1
    • acei enzyme inhibitor and logistic regression: 1, 2, 3, 4
    • acei enzyme inhibitor and logistic regression model: 1
    • acei enzyme inhibitor and logistic regression multivariate analysis: 1
    • acute respiratory distress syndrome and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • acute respiratory distress syndrome and logistic regression model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • acute respiratory distress syndrome and logistic regression multivariate analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • acute respiratory distress syndrome and los paciente: 1, 2
    • acute respiratory distress syndrome and low oxygenation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory distress syndrome immune response and logistic regression: 1
    • logistic regression and low oxygenation: 1, 2, 3
    • logistic regression model and low oxygenation: 1